HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence

Immunogenetics

Volumn 68, Issue 2, 2016, Pages 145-155

  Wang, Yuge ^a   Kapoor, Pratibha ^c   Parks, Robert ^d   Silva Sanchez, Aaron ^a,b   Alam, S Munir ^d   Verkoczy, Laurent ^d   Liao, Hua Xin ^d   Zhuang, Yingxin ^b   Burrows, Peter ^a   Levinson, Michael ^a   Elgavish, Ada ^b   Cui, Xiangqin ^c   Haynes, Barton F ^d   Schroeder, Harry ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complementarity determining region (CDR H3); Epitope; HIV 1 envelope protein; Immunoglobulin DH gene

Indexed keywords

COMPLEMENTARITY DETERMINING REGION; EPITOPE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; GP140 ENVELOPE PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BINDING; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN;

ALLELE; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; B LYMPHOCYTE; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; EPITOPE MAPPING; GENETICS; GENOTYPE; GERM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; POSITION WEIGHT MATRIX; PROCEDURES; PROTEIN CONFORMATION; PROTEIN MOTIF; SEQUENCE ALIGNMENT; VIROLOGY;

ALLELES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EPITOPE MAPPING; EPITOPES; GENOTYPE; GERM CELLS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MICE; MOLECULAR SEQUENCE DATA; POSITION-SPECIFIC SCORING MATRICES; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT;

EID: 84955737898     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-015-0890-x     Document Type: Article

References (44)

1. Alam SM, Scearce RM, Parks RJ, Plonk K, Plonk SG, Sutherland LL, Gorny MK, Zolla-Pazner S, Vanleeuwen S, Moody MA et al (2008) Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection. J Virol 82:115–125
2. Alt FW, Blackwell TK, Yancopoulos GD (1987) Development of the primary antibody repertoire. Science 238:1079–1087
3. Banerjee K, Klasse PJ, Sanders RW, Pereyra F, Michael E, Lu M, Walker BD, Moore JP (2010) IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines. AIDS Res Hum Retroviruses 26:445–458
4. Binley JM, Sanders RW, Clas B, Schuelke N, Master A, Guo Y, Kajumo F, Anselma DJ, Maddon PJ, Olson WC et al (2000) A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J Virol 74:627–643
5. Brunel FM, Zwick MB, Cardoso RM, Nelson JD, Wilson IA, Burton DR, Dawson PE (2006) Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody. J Virol 80:1680–1687
6. Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA (2005) Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22:163–173
7. Eisenberg D (1984) Three-dimensional structure of membrane and surface proteins. Annu Rev Biochem 53:595–623
8. Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG (2000) The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol 18:495–527
9. Gu H, Forster I, Rajewsky K (1990) Sequence homologies, N sequence insertion and JH gene utilization in VH-D-JH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation. EMBO J 9:2133–2140
10. Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang YK, Depetris R, Marozsan AJ, Sanders RW et al (2011) Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A 108:11440–11445
11. Heilkenbrinker U, Dietrich R, Didier A, Zhu K, Lindback T, Granum PE, Martlbauer E (2013) Complex formation between NheB and NheC is necessary to induce cytotoxic activity by the three-component Bacillus cereus Nhe enterotoxin. PLoS One 8:e63104
12. Ippolito GC, Schelonka RL, Zemlin M, Ivanov II, Kobayashi R, Zemlin C, Gartland GL, Nitschke L, Pelkonen J, Fujihashi K et al (2006) Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J Exp Med 203:1567–1578
13. Ivanov II, Link JM, Ippolito GC, Schroeder HW Jr (2002) Constraints on hydropathicity and sequence composition of HCDR3 are conserved across evolution. In: Zanetti M, Capra JD (eds) The antibodies. Taylor and Francis Group, London, pp 43–67
14. Ivanov II, Schelonka RL, Zhuang Y, Gartland GL, Zemlin M, Schroeder HW Jr (2005) Development of the expressed Ig CDR-H3 repertoire is marked by focusing of constraints in length, amino acid use, and charge that are first established in early B cell progenitors. J Immunol 174:7773–7780
15. Kunert R, Wolbank S, Stiegler G, Weik R, Katinger H (2004) Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody. AIDS Res Hum Retroviruses 20:755–762
16. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105–132
17. LeBien TW, Tedder TF (2008) B lymphocytes: how they develop and function. Blood 112:1570–1580
18. Liao HX, Sutherland LL, Xia SM, Brock ME, Scearce RM, Vanleeuwen S, Alam SM, McAdams M, Weaver EA, Camacho Z et al (2006) A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology 353:268–282
19. Liao HX, Bonsignori M, Alam SM, McLellan JS, Tomaras GD, Moody MA, Kozink DM, Hwang KK, Chen X, Tsao CY et al (2013) Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity 38:176–186
20. Lutje Hulsik D, Liu YY, Strokappe NM, Battella S, El Khattabi M, McCoy LE, Sabin C, Hinz A, Hock M, Macheboeuf P et al (2013) A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition. PLoS Pathog 9:e1003202
21. Mahmoud TI, Schroeder HW Jr, Kearney JF (2011) Limiting CDR-H3 diversity abrogates the antibody response to the bacterial polysaccharide alpha 1→3 dextran. J Immunol 187:879–886
22. McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, Khayat R, Louder R, Pejchal R, Sastry M, Dai K et al (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480:336–343
23. Meffre E, Milili M, Blanco-Betancourt C, Antunes H, Nussenzweig MC, Schiff C (2001) Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J Clin Invest 108:879–886
24. Nadel B, Feeney AJ (1995) Influence of coding-end sequence on coding-end processing in V(D)J recombination. J Immunol 155:4322–4329
25. Nguyen HH, Zemlin M, Ivanov II, Andrasi J, Zemlin C, Vu HL, Schelonka R, Schroeder HW Jr, Mestecky J (2007) Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. J Virol 81:9331–9338
26. Nitschke L, Kestler J, Tallone T, Pelkonen S, Pelkonen J (2001) Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage. J Immunol 166:2540–2552
27. Ofek G, McKee K, Yang Y, Yang ZY, Skinner J, Guenaga FJ, Wyatt R, Zwick MB, Nabel GJ, Mascola JR et al (2010) Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region. J Virol 84:2955–2962
28. Schelonka RL, Ivanov II, Jung DH, Ippolito GC, Nitschke L, Zhuang Y, Gartland GL, Pelkonen J, Alt FW, Rajewsky K et al (2005) A single DH gene segment creates its own unique CDR-H3 repertoire and is sufficient for B cell development and immune function. J Immunol 175:6624–6632
29. Schelonka RL, Zemlin M, Kobayashi R, Ippolito GC, Zhuang Y, Gartland GL, Szalai A, Fujihashi K, Rajewsky K, Schroeder HW Jr (2008) Preferential use of DH reading frame 2 alters B cell development and antigen-specific antibody production. J Immunol 181:8409–8415
30. Schroeder HW Jr, Zemlin M, Khass M, Nguyen HH, Schelonka RL (2010) Genetic control of DH reading frame and its effect on B-cell development and antigen-specific antibody production. Crit Rev Immunol 30:327–344
31. Shukla NM, Salunke DB, Balakrishna R, Mutz CA, Malladi SS, David SA (2012) Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer. PLoS One 7:e43612
32. Stamatatos L, Lim M, Cheng-Mayer C (2000) Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates. AIDS Res Hum Retroviruses 16:981–994
33. Stamatos NM, Mascola JR, Kalyanaraman VS, Louder MK, Frampton LM, Birx DL, VanCott TC (1998) Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140. J Virol 72:9656–9667
34. Swanson CL, Wilson TJ, Strauch P, Colonna M, Pelanda R, Torres RM (2010) Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J Exp Med 207:1485–1500
35. Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H (2007) Autoreactivity in human IgG+ memory B cells. Immunity 26:205–213
36. Trad A, Tanasa RI, Lange H, Zemlin M, Schroeder HWJ, and Lemke H (2014) Clonal progression during the thymus-dependent B cell response to the hapten oxazolone depends on the immunoglobulin DH gene repertoire
37. Vale AM, Kapoor P, Skibinski GA, Elgavish A, Mahmoud TI, Zemlin C, Zemlin M, Burrows PD, Nobrega A, Kearney JF et al (2013) The link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation. J Exp Med 210:875–890
38. Verkoczy L, Chen Y, Bouton-Verville H, Zhang J, Diaz M, Hutchinson J, Ouyang YB, Alam SM, Holl TM, Hwang KK et al (2011) Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH × VL knockin mice reveals multiple tolerance controls. J Immunol 187:3785–3797
39. Verkoczy L, Chen Y, Zhang J, Bouton-Verville H, Newman A, Lockwood B, Scearce RM, Montefiori DC, Dennison SM, Xia SM et al (2013) Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses. J Immunol 191:2538–2550
40. Vinuesa CG, Chang PP (2013) Innate B cell helpers reveal novel types of antibody responses. Nat Immunol 14:119–126
41. Wells TJ, Whitters D, Sevastsyanovich YR, Heath JN, Pravin J, Goodall M, Browning DF, O’Shea MK, Cranston A, De Soyza A et al (2014) Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing. J Exp Med 211:1893–1904
42. West AP Jr, Scharf L, Scheid JF, Klein F, Bjorkman PJ, Nussenzweig MC (2014) Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 156:633–648
43. Yates NL, Liao HX, Fong Y, deCamp A, Vandergrift NA, Williams WT, Alam SM, Ferrari G, Yang ZY, Seaton KE et al (2014) Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci Trans Med 6:228ra239
44. Zemlin M, Schelonka RL, Ippolito GC, Zemlin C, Zhuang Y, Gartland GL, Nitschke L, Pelkonen J, Rajewsky K, Schroeder HW Jr (2008) Regulation of repertoire development through genetic control of DH reading frame preference. J Immunol 181:8416–8424